GGrantScoutHQCreate alert

Small business grants — Page 11

Current opportunities whose applicant data, eligibility or category identifies qualifying small businesses, startups, SBIR or STTR activity.

502 current opportunities · showing 241–264

OPENNonprofit & Community Services

Home Study and Post-Release Services for Unaccompanied Alien Children

Administration for Children and Families - ORR

This NOFO is modified. Changes are made to Step 1: Review the Opportunity. The Office of Refugee Resettlement (ORR) provides temporary housing and care for children who arrive in the United States alone. These are children who are under 18 years old, don't have legal permission to be in the U.S

Deadline
Oct 2, 2027
Funding
Estimated total program funding: $555,000,000
Check fit and official source →
OPENTechnology & Innovation

BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

National Institutes of Health

This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks transformative, cutting-edge, and innovative research that embraces new technologies, ideas, and approaches to understand brain circuit function and contributions to

Deadline
Oct 5, 2027
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENEducation

Advanced Technological Education (ATE)

U.S. National Science Foundation

With a focus on two-year Institutions of Higher Education (IHEs), the Advanced Technological Education (ATE) program supports the education of technicians for the high-technology fields that drive our nation's economy. The program involves partnerships between academic institutions (grades 7-12

Deadline
Oct 8, 2027
Funding
Estimated total program funding: $74,000,000
Check fit and official source →
OPENHealth & Medical

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

National Institutes of Health

The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcript-directed therapeutics, such as oligonucleotides and viral-based gene therapies, for ultra-rare neu

Deadline
Oct 9, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer

Deadline
Oct 9, 2027
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this

Deadline
Oct 13, 2027
Funding
Estimated total program funding: $500,000
Check fit and official source →
OPENHealth & Medical

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty position

Deadline
Oct 15, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)

National Institutes of Health

The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty position

Deadline
Oct 15, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage cooperative agreement applications to support early stage clinical trials of novel mechanism of action, investigational drugs, or novel neuromodulatory devices for the treatment of psychiatric disorders in areas of unmet medica

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot research developing and testing novel psychosocial interventions and/or targets. Consistent with NI

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

National Institutes of Health

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas wit

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

National Institutes of Health

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot research developing and testing novel psychosocial interventions and/or targets. Consistent with NIMH&a

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)

National Institutes of Health

This R61/R33 concept complements NIMHs suite of clinical trial NOFOs by supporting feasibility and infrastructure development (R61) followed by well-powered clinical trials (R33) to test the effectiveness of system interventions and strategies for improving the organization, delivery, coordination,

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

National Institutes of Health

Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required). As part of NIMH's clinical trials pipeline NOFOs, this announcement supports confirmatory efficacy testing of non pharmacological therapeutic and preventive interventio

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Cl

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

National Institutes of Health

Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required). This NOFO is a key element of NIMHs set of NOFOs to support clinical trials research across the intervention development and testing pipeline. The NOFO supports (1) clinical

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)

National Institutes of Health

Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R01 Clinical Trial Required). As part of NIMH's clinical trials pipeline NOFOs, this announcement encourages pilot effectiveness studies focused on 1) optimizing the effectiveness of preventive and therapeutic inte

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

National Institutes of Health

NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Cl

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development of statistical methodology necessary for improving methods to analyze vision health data using exist

Deadline
Oct 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

National Institutes of Health

The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting well designed and well executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and

Deadline
Oct 19, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) solicits applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagn

Deadline
Oct 20, 2027
Funding
Estimated total program funding: $2,400,000
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a si

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall und

Deadline
Oct 21, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of I

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →

Application guidance

Verify the official size standard, ownership, place of business, research partner, industry and commercialization requirements. A listing is not a universal small-business grant.